No. of patients | Per cent | Per cent in NCEPOD | |
---|---|---|---|
Type of line complication | |||
Line misplacement/accidental removal | 9 | 5 | 3 |
Line occlusion | 4 | 2 | 2 |
Local line site infection/phlebitis | 4 | 2 | 10 |
TPN extravasation | 4 | 2 | 1 |
Other | 3 | 2 | 1 |
Systemic line infection | 3 | 2 | 5 |
Not documented | 2 | 1 | 16 |
Type of metabolic complication | |||
Abnormal LFTs | 35 | 18 | Not documented |
Hypomagnesaemia | 23 | 12 | 10 |
Hypophosphataemia | 18 | 9 | 18 |
Hypokalaemia | 16 | 8 | 11 |
Hyponatraemia | 14 | 7 | 6 |
Hyperphosphataemia | 9 | 5 | 4 |
Hyperkalaemia | 8 | 9 | 4 |
Hypermagnesaemia | 3 | 2 | 3 |
Hypernatraemia | 3 | 2 | 3 |
Hyperglycaemia | 1 | 1 | 8 |
LFT, liver function test; NCEPOD, National Confidential Enquiry into Patient Outcome and Death; TPN, total parenteral nutrition.